Osteoporosis takes an enormous toll among postmenopausal women.A 50-year-old woman in the United States has a 40 percent lifetimerisk of an osteoporotic fracture. One woman in three and oneman in nine older than 80 years of age will sustain a hip fractureat some point, and 15 to 20 percent of these patients will diefrom attendant complications. Osteoporosis is, to a remarkabledegree, a disease of Western civilization, and we are now seeingthe beginnings of a worldwide osteoporosis pandemic, as thepopulation of the developing world ages and assumes a more Westernlifestyle.
From Beth Israel Deaconess Medical Center and Harvard Medical School, Boston.
This article has been cited by other articles:
Baillie, C.
(2007). Continuing alendronate for an additional 5 years maintained bone mineral density in postmenopausal women. Evid. Based Med.
12: 70-70
[Full Text]
Kondo, H., Nifuji, A., Takeda, S., Ezura, Y., Rittling, S. R., Denhardt, D. T., Nakashima, K., Karsenty, G., Noda, M.
(2005). Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System. J. Biol. Chem.
280: 30192-30200
[Abstract][Full Text]
Strewler, G. J.
(2005). Long-Term Bisphosphonates for Osteoporosis: An Introduction. IBMS BoneKEy
2: 6-9
[Full Text]
(2004). Alendronate: Safe and Effective During One Decade of Use. JWatch Women's Health
2004: 6-6
[Full Text]
Previous
